Last reviewed · How we verify
Parabolan — Competitive Intelligence Brief
unknown
Polymerase acidic protein, Androgen receptor
Other
Live · refreshed every 30 min
Target snapshot
Parabolan (trenbolone hexahydrobenzylcarbonate). Parabolan works by binding to androgen receptors in the body, mimicking the effects of testosterone and promoting muscle growth and development.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Parabolan TARGET | trenbolone hexahydrobenzylcarbonate | unknown | Polymerase acidic protein, Androgen receptor |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
Cite this brief
Drug Landscape (2026). Parabolan — Competitive Intelligence Brief. https://druglandscape.com/ci/trenbolone-hexahydrobenzylcarbonate. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing